Displaying 1041 - 1060 of 4528
2001005 Informal Interpretation
FTC Challenges Consummated Merger of Companies that Market Body-Worn Camera Systems to Large Metropolitan Police Departments
FTC Announces Agenda for Jan. 9 Workshop, Non-Competes in the Workplace: Examining Antitrust and Consumer Protection Issues
Statement of Gail Levine, Deputy Director of FTC Bureau of Competition, Regarding the Announcement that Illumina Inc. has Abandoned Its Proposed Acquisition of Pacific Biosciences of California
FTC Alleges Post Holdings, Inc.’s Proposed Acquisition of TreeHouse Foods, Inc.’s Private Label Ready-to-Eat Cereal Business Will Harm Competition
FTC Chairman Simons Announces Senior Appointments in Bureau of Competition
Third Point LLC
Investment advisor Third Point LLC and three funds that it controls have agreed to settle Federal Trade Commission charges that the funds violated the premerger notification and waiting period requirements of the Hart-Scott-Rodino Act, or HSR Act, after they acquired the voting securities of DowDuPont Inc. According to the complaint, on Aug. 31, 2017, the shares of Dow Inc. held by the three Third Point funds – Third Point Partners Qualified L.P., Third Point Ultra, Ltd., and Third Point Offshore Fund Ltd. – converted to shares of the newly formed DowDuPont Inc. following the merger of Dow Inc. and E.I. du Pont de Nemours & Company. The three funds have agreed to collectively pay $609,810 in civil penalties, and they, together with Third Point LLC, will be barred from committing future violations of the HSR Act in connection with corporate consolidations.
1912001 Informal Interpretation
FTC Challenges Illumina’s Proposed Acquisition of PacBio
Statement of the Federal Trade Commission in the matter of Roche Holding/Spark Therapeutics
Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.
FTC Approves Final Order Imposing Conditions on NEXUS Gas Transmission, LLC’s Acquisition of Generation Pipeline LLC
Federal Trade Commission's Statement of Public Interest
FTC Comment to Texas Medical Board on Its Proposed Rule 193.13 to Add Supervision Requirements for Texas-Certified Nurse Anesthetists
FTC Comment to Texas Medical Board Raises Competitive Concerns about Proposed Rule Imposing Additional Supervisory Requirements on Texas-Certified Nurse Anesthetists
1912002 Informal Interpretation
Agency Information Collection Activities; Submission for OMB Review; Comment Request (HSR Rules)
Displaying 1041 - 1060 of 4528